Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin or Vancomycin for a Skin Infection in the Outpatient Setting

OBJECTIVE: Hospital admission is a key cost driver among patients with skin and soft tissue infections (SSTI). Data suggest that many SSTI patients are hospitalized unnecessarily and can be managed effectively and safely in an outpatient setting at a substantially lower cost. Oritavancin (ORI) is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lodise, Thomas P, Palazzolo, Christina, Reksc, Kerry, Packnett, Elizabeth, Redell, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902011/
https://www.ncbi.nlm.nih.gov/pubmed/31844636
http://dx.doi.org/10.1093/ofid/ofz475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6902011/
https://www.ncbi.nlm.nih.gov/pubmed/31844636
http://dx.doi.org/10.1093/ofid/ofz475

Ejemplares similares